Promedior Inc. a biotechnology company focused on advancing new therapeutics to address treatment for fibrosis, recently announced that Olga Pozdynakova of Brigham and Women’s Hospital Boston will be presenting further data on the firm’s ongoing Phase 2 clinical trial ... Read more